Welcome to our dedicated page for Astera Labs SEC filings (Ticker: ALAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Astera Labs's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Astera Labs's regulatory disclosures and financial reporting.
Astera Labs, Inc. Chief Executive Officer Mohan Jitendra, through a living trust, reported open-market sales of Common Stock. On April 15, 2026, the living trust sold 2,767 shares at $174.5682 per share and 200 shares at $175.03 per share.
The filing states these sales occurred automatically under a pre-arranged Rule 10b5-1 trading plan adopted on December 1, 2025, indicating they were scheduled in advance. Following the trades, the living trust holds 4,405,015 shares, and the filing also lists additional indirect holdings in multiple estate-planning trusts and a direct holding of 1,452,739 shares of Common Stock.
Astera Labs submitted a Form 144 notice reporting proposed transfers of common stock by Jitendra Mohan and related trust. The excerpt lists four planned transfers dated 12/01/2025 totaling 204,750 shares from RSU issuances, and three sales filed as completed in the past three months: 94,971, 157,500, and 123,750 shares with corresponding gross proceeds shown.
Astera Labs, Inc. reported that a living trust associated with Chief Executive Officer Mohan Jitendra sold 123,750 shares of Common Stock in open-market transactions. The trust sold 99,023 shares at a weighted average price of $149.5322 per share and 24,727 shares at a weighted average price of $150.2535 per share.
The filing states these sales occurred automatically under a Rule 10b5-1 trading plan adopted on December 1, 2025. After the sales, the living trust reported holding 4,407,982 shares indirectly, and the filing also lists additional indirect holdings in several estate planning trusts and 1,452,739 shares held directly.
Astera Labs, Inc. director Manuel Alba reported that entities associated with him executed open-market sales of 183,000 shares of Astera Labs common stock on April 1, 2026. The trades were carried out automatically under a Rule 10b5-1 trading plan adopted on May 29, 2025, at weighted-average prices between approximately $105.85 and $111.27 per share.
After these sales, the Alba 2003 Living Trust held 1,424,498 shares, Casa Alameda 2007, LLC held 319,863 shares, Alba’s spouse held 5,000 shares, and he held 2,351 shares directly. The filing notes that Alba disclaims beneficial ownership of the trust and LLC shares beyond any pecuniary interest.
Astera Labs, Inc. General Counsel and Secretary Philip Mazzara sold a total of 10,000 shares of common stock in open-market transactions on April 1, 2026, at weighted average prices ranging from just over $105 to about $111 per share.
The filing notes these sales occurred automatically under a pre-arranged Rule 10b5-1 trading plan adopted on May 29, 2025. Following the transactions, Mazzara continues to hold 118,584 shares of Astera Labs common stock directly.
ALAB related sale notice filed via Form 144. The filing lists 150,000 shares of Common stock proposed for sale, dated 04/01/2026. The securities were acquired privately on 03/21/2018 as a Private Acquisition from Issuer or an Affiliate and the filing shows a dollar amount of $16,440,000.00.
ALAB affiliate intends to sell 33,000 shares. A Form 144 filing lists 33,000 Common shares associated with Morgan Stanley Smith Barney LLC, a proposed aggregate amount of $3,616,800.00, and indicates the securities were privately acquired from the issuer or an affiliate on 11/30/2018. The filing date is 04/01/2026 and the shares are listed for sale on NASDAQ.
ALAB proposed the sale of 170,000 shares of Common Stock under Form 144. The filing lists Morgan Stanley Smith Barney LLC, Executive Financial Services, as the filer and shows the shares were acquired on 03/21/2018 by private acquisition from issuer or an affiliate. The filing records $18,632,000.00 on the securities line and includes an anchor date of 04/01/2026.
Astera Labs Inc Schedule 13G/A amendment: The Vanguard Group reports zero beneficial ownership of Astera Labs common stock following an internal realignment that disaggregated certain subsidiaries' holdings, in accordance with SEC Release No. 34-39538.
The filing states Vanguard’s subsidiaries will report beneficial ownership separately and that Vanguard no longer is deemed to beneficially own the shares previously reported by those units.
Astera Labs filed a shelf registration on Form S-3ASR to register up to 5,578,474 shares of Common Stock for resale by selling stockholder Amazon.com NV Investment Holdings LLC. The prospectus states the company will not receive any proceeds from these resales and that the shares consist of warrants exercisable into Common Stock.
The prospectus notes 1,248,707 shares underlying the warrants were vested and exercisable as of February 28, 2026, and that percentage ownership calculations use 171,246,523 shares outstanding as of that date. The selling stockholder’s post‑offering ownership is shown assuming sale of all registered shares.